Newsroom
Sorted by: Latest
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 30 June 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 30 June 2026 Number of Public Shares Purchased: 32,631 S...
-
Teledyne FLIR Defense Partners With STORM to Extend Black Recon Missions Across More Vehicle Platforms
OSLO, Norway--(BUSINESS WIRE)--Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), and STORM have announced a partnership that will bring Teledyne FLIR’s Black Recon™ vehicle reconnaissance system to RADS™, the Rapid Adapt and Deploy System. As a RADS Application Partner, Teledyne FLIR gains a standardised route to field Black Recon across many more vehicle types, while joining STORM’s growing ecosystem of certified technology partners. The partnership was signed at E...
-
Adenia Acquires Majority Stake in Minet Group From Capitalworks
BEAU PLAN, Mauritius--(BUSINESS WIRE)--Africa focused private equity firm, Adenia Partners, has acquired a majority stake in Minet Group, the insurance brokerage and risk advisory firm...
-
Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.
JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company acquired Helvoet Polymer Technologies B.V. (“Helvoet”), a Contract Development and Manufacturing Organization (CDMO), based in Europe and with operations in India focused on microfluidics, diagnostics, and drug delivery. The transaction was valued at a purchase price of €90 million (excluding working capital, other customary adjustments, and acquisition-related costs), or approximately $103 million...
-
Kaleon élargit son portefeuille de sites avec un premier actif en gestion pour compte de tiers depuis son introduction en Bourse, en remportant l’appel d’offres pour la gestion du Castello di Vogogna
MILAN--(BUSINESS WIRE)--Regulatory News: Kaleon S.p.A (« Kaleon » ou la « Société »), une société liée à la famille Borromeo, spécialisée dans la gestion et la valorisation touristique du patrimoine artistique, naturel et culturel, cotée sur Euronext Growth Milan (Ticker : KLN) et Euronext Growth Paris (Ticker : ALKLN) - annonce avoir remporté l’appel d’offres pour la gestion du château Castello di Vogogna, au cœur du village médiéval éponyme, dans la région Verbano-Cusio-Ossola, pendant une du...
-
Kaleon wins the tender to manage the first third-party asset since listing: the Castle of Vogogna joins the portfolio
MILAN--(BUSINESS WIRE)--Regulatory News: Kaleon S.p.A. (“Kaleon” or the “Company”), a company linked to the Borromeo family and specialized in the management and enhancement of major artistic, natural and museum heritage assets for tourism purposes, listed on Euronext Growth Milan (Ticker: KLN) and Euronext Growth Paris (Ticker: ALKLN), announces that it has been awarded the management of the Castle of Vogogna, located in the heart of the medieval village of the same name in the Verbano-Cusio-O...
-
Duncan Welsh Joins Antin’s Investor Relations Team in Australia
PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: Antin Infrastructure Partners (Paris:ANTIN), a leading private equity firm focused on infrastructure investments, announces the appointment of Duncan Welsh as Investor Relations Principal, effective immediately. Mr. Welsh will establish an investor-focused office in Melbourne, Australia, complementing Antin’s existing office in Seoul, South Korea. His appointment enables Antin to serve its fund investor base in the region more closely...
-
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (P...
-
Yubico Joins European Cyber Security Organisation (ECSO)
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Yubico (NASDAQ STOCKHOLM: YUBICO), the pioneer of phishing-resistant authentication and creator of the original hardware-backed passkey, the YubiKey, today announced its official acceptance as a member of the European Cyber Security Organisation (ECSO), a pan-European public-private federation focused on empowering European cybersecurity communities. The membership empowers both Yubico and ECSO to accelerate a shared commitment to advancing phishing-...
-
Yubico tritt der European Cyber Security Organisation (ECSO) bei
STOCKHOLM, SCHWEDEN--(BUSINESS WIRE)--Yubico (NASDAQ STOCKHOLM: YUBICO), Pionier der Phishing-resistenten Authentifizierung und Entwickler des sichersten hardwaregestützten Passkeys, des YubiKey, gab heute seine offizielle Aufnahme als Mitglied der European Cyber Security Organisation (ECSO) bekannt, einem paneuropäischen öffentlich-privaten Zusammenschluss, der sich auf die Stärkung der europäischen Cybersicherheitsgemeinschaften konzentriert. Die Mitgliedschaft ermöglicht es sowohl Yubico als...